✦ LIBER ✦

Natural killer cell activity in patients with pernicious anemia

✍ Scribed by J. A. Vargas; M. Alvarez-Mon; L. Manzano; A. Albillos; A. Fernández-Corugedo; J. C. Gea-Banacloche; F. M. Gonzalez; A. Durántez

Book ID: 112724333
Publisher: Springer US
Year: 1995
Tongue: English
Weight: 348 KB
Volume: 40
Category: Article
ISSN: 0163-2116
DOI: 10.1007/bf02285205

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Natural killer cell activity in patients

Natural killer cell activity in patients with septic shock

✍ Patricio Maturana; Javier Puente; Dante Miranda; Cecilia Sepulveda; Marion E. Wo 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 366 KB

Reduced natural killer activity in patie

Reduced natural killer activity in patients with fanconi's anemia and in family members

✍ P. Froom; E. Aghai; J.B. Dobinsky; M. Quitt; N. Lahat 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 250 KB

Reduced natural killer cell activity in

Reduced natural killer cell activity in patients with systemic sclerosis

✍ Edward B. Miller; John C. Hiserodt; Laverne E. Hunt; Virginia D. Steen; Thomas A 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 806 KB

Low natural killer cell activity in pati

Low natural killer cell activity in patients with malignant lymphoma

✍ Thomas Tursz; Marie-Christine Dokhelar; Marc Lipinski; Jean-Louis Amiel 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 281 KB 👁 2 views

Analysis of natural killer activity and

Analysis of natural killer activity and natural killer cell subsets in patients with bladder cancer

✍ Tatsuo Morita; Akihiko Tokue; Nagahiro Minato 📂 Article 📅 1990 🏛 Springer-Verlag 🌐 English ⚖ 425 KB

Lymphokine-activated killer cell and nat

Lymphokine-activated killer cell and natural killer cell activities in patients with systemic sclerosis

✍ Thomas V. Kantor; Theresa L. Whiteside; Diana Friberg; Robert B. Buckingham; Tho 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB 👁 2 views

Objective. To determine the ability of T lymphocytes and natural killer (NK) cells from patients with systemic sclerosis (SSc) to respond to cytokines and to generate immune effector cells. Methods. The numbers and percentages of peripheral blood T and NK cells were examined by 2-color flow cytometr